Corrigendum to "Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling" [Pharmacol. Res. 119 (2017) 72–88]. (November 2021) - Que, Zhongyou; Wang, Ping; Hu, Yi; Xue, Yixue; Liu, Xiaobai; Qu, Chengbin; Ma, Jun; Liu, Yunhui